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Introduction
Microvascular decompression (MVD) of the trigeminal
nerve has been so far reported to be effective in 12/19
SUNCT and SUNA patients (63 %) with neurovascular
compression.
Aims
We report the outcome of MVD, using Jannetta proce-
dure, in nine cases of medically intractable chronic
SUNCT and SUNA patients.
Methods
Nine patients with chronic SUNCT and SUNA with a
vascular loop indenting or distorting the trigeminal nerve
ipsilaterally to the side of the pain demonstrable on MRI
scan were offered MVD of the trigeminal nerve. All the
patients failed to respond or tolerate adequate dosages of:
lamotrigine, topiramate, oxcarbazepine, carbamazepine,
duloxetine, pregabalin or gabapentin and greater occipital
nerve blocks. Intravenous lidocaine improved the pain
only during infusion in some of them.
Results
Seven SUNCT and two SUNA patients underwent MVD
of the trigeminal nerve. They all had multiple daily severe
headache attacks at baseline. At a median follow-up of 15
months (range: 8-30 months) after the operation, four
patients became and remained pain free, one patient each
had 90%, 70% and 50% improvement, respectively. The
patient who improved by 50% was rendered pain free on
preventive treatments. Two patients became pain free for
12 months, before pain returned. One patient suffered a
CSF leak after the procedure.
Conclusions
MVD of the trigeminal nerve was effective in 7/9 SUNCT/
SUNA patients (78%). Although longer follow-up is
needed to establish the long term outcome of this proce-
dure, these preliminary data support the role of MVD in
the surgical management of SUNCT and SUNA.
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